The current article discusses elements of the health economics profile of new pharmaceuticals, specifically looking at the challenges of providing a healthcare system, the concepts around the provision of value-based healthcare systems and calculating the cost-effectiveness of new medicines.
Join now to get access to:
Not sure yet? Read one of our free editorials to see what you’re missing out on!